RE:RE:Shelf ProspectusFredgoodwinson, you are worried about achieving commercialism while still keeping the share count under 200 million. You should hear yourself. If you were blessed enough to recieve FDA approval for a viable cancer treatment and the application to other cancers that it would represent, you could have a billion shares out there and the sp would still be $100. If you are confident that a cure is there then all that should matter is how quickly they can finish their testing not the share count.